↓ Skip to main content


Overview of attention for book
Cover of 'N-Acetylaspartate'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 A Brief Overview of N -Acetylaspartate and N -Acetylaspartylglutamate
  3. Altmetric Badge
    Chapter 2 Expression of N -Acetylaspartate and N -Acetylaspartylglutamate in the Nervous System
  4. Altmetric Badge
    Chapter 3 N -Acetylaspartate Metabolism in Neural Cells
  5. Altmetric Badge
    Chapter 4 Naa Synthesis and Functional Roles
  6. Altmetric Badge
    Chapter 5 Identity of the High-Affinity Sodium/Carboxylate Cotransporter NaC3 as the N -Acetyl-L-Aspartate Transporter
  7. Altmetric Badge
    Chapter 6 Canavan Disease: Studies on the Knockout Mouse
  8. Altmetric Badge
    Chapter 7 Functions Of N -Acetylaspartate and N -Acetylaspartylglutamate in Brain
  9. Altmetric Badge
    Chapter 8 Control of Brain Volume during Hypoosmolality and Hyperosmolality
  10. Altmetric Badge
    Chapter 9 Physiological Role of N -Acetylaspartate
  11. Altmetric Badge
    Chapter 10 Defective Myelin Lipid Synthesis as a Pathogenic Mechanism of Canavan Disease
  12. Altmetric Badge
    Chapter 11 Mutation Analysis of the Aspartoacylase Gene in Non-Jewish Patients with Canavan Disease
  13. Altmetric Badge
    Chapter 12 Does ASPA Gene Mutation in Canavan Disease Alter Oligodendrocyte Development?
  14. Altmetric Badge
    Chapter 13 Quantitation of NAA in the Brain by Magnetic Resonance Spectroscopy
  15. Altmetric Badge
    Chapter 14 N-Acetyl-L-Aspartate in Multiple Sclerosis
  16. Altmetric Badge
    Chapter 15 NAA and higher cognitive function in humans.
  17. Altmetric Badge
    Chapter 16 In Vivo NMR Measures of NAA and the Neurobiology of Schizophrenia
  18. Altmetric Badge
    Chapter 17 N -Acetylaspartate as a Marker of Neuronal Injury in Neurodegenerative Disease
  19. Altmetric Badge
    Chapter 18 Regulation of NAA-Synthesis in the Human Brain in Vivo: Canavan’s Disease, Alzheimer’s Disease and Schizophrenia
  20. Altmetric Badge
    Chapter 19 Magnetic Resonance Spectroscopy for Monitoring Neuronal Integrity in Amyotrophic Lateral Sclerosis
  21. Altmetric Badge
    Chapter 20 Hypoacetylaspartia: Clinical and Biochemical Follow-Up of a Patient
  22. Altmetric Badge
    Chapter 21 Cellular localization of NAAG.
  23. Altmetric Badge
    Chapter 22 Synthesis of N-acetylaspartyl-glutamate (NAAG) and N-acetylaspartate (NAA) in axons and glia of the crayfish medial giant nerve fiber.
  24. Altmetric Badge
    Chapter 23 NAAG as a neurotransmitter.
  25. Altmetric Badge
    Chapter 24 Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
  26. Altmetric Badge
    Chapter 25 N-acetylaspartylglutamate (NAAG) in spinal cord injury and disease.
  27. Altmetric Badge
    Chapter 26 N-acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher disease.
  28. Altmetric Badge
    Chapter 27 Concluding Remarks
Attention for Chapter 6: Canavan Disease: Studies on the Knockout Mouse
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

2 Wikipedia pages


27 Dimensions

Readers on

15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Canavan Disease: Studies on the Knockout Mouse
Chapter number 6
Book title
Published in
Advances in experimental medicine and biology, June 2006
DOI 10.1007/0-387-30172-0_6
Pubmed ID
Book ISBNs
978-0-387-30171-6, 978-0-387-30172-3

Matalon R, Michals-Matalon K, Surendran S, Tyring SK, Reuben Matalon, Kimberlee Michals-Matalon, Sankar Surendran, Stephen K. Tyring


Canavan disease (CD) is an autosomal recessive disorder, characterized by spongy degeneration of the brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA. Clinically, patients with CD have macrocephaly, mental retardation and hypotonia. A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated NAA. Molecular studies of the mouse brain showed abnormal expression of multiple genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology in the CD mouse.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 33%
Student > Bachelor 5 33%
Student > Postgraduate 2 13%
Other 1 7%
Unknown 2 13%
Readers by discipline Count As %
Medicine and Dentistry 7 47%
Agricultural and Biological Sciences 2 13%
Biochemistry, Genetics and Molecular Biology 2 13%
Computer Science 1 7%
Neuroscience 1 7%
Other 1 7%
Unknown 1 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2018.
All research outputs
of 12,532,910 outputs
Outputs from Advances in experimental medicine and biology
of 3,195 outputs
Outputs of similar age
of 274,139 outputs
Outputs of similar age from Advances in experimental medicine and biology
of 270 outputs
Altmetric has tracked 12,532,910 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,195 research outputs from this source. They receive a mean Attention Score of 3.4. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,139 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 270 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.